Status:
COMPLETED
Efficacy and Neural Mediators of Response to Trauma Management Therapy for PTSD
Lead Sponsor:
VA Office of Research and Development
Conditions:
PTSD
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Social difficulties are serious and frequent complicating factors in the treatment of post-traumatic stress disorder (PTSD). To better understand how treatment of post-traumatic stress disorder impact...
Detailed Description
PTSD is associated with significant interpersonal difficulties that interfere with functioning. As such, this work is intended to evaluate the empirical support for a novel treatment that fills a sign...
Eligibility Criteria
Inclusion
- Male and female veterans of all ethnicities
- Meet diagnostic criteria for post-traumatic stress disorder (assessed by study staff)
- Fluent in English
- Able to see computer display clearly
- Able to provide informed consent
- Able to follow written or verbal instructions
Exclusion
- history of seizures
- history of stroke
- Cushing's syndrome
- history of moderate to severe traumatic brain injury
- electroconvulsive therapy within 5 years
- history of chemotherapy for cancer
- contraindications to fMRI
- pregnancy
- diagnosis of schizophrenia, schizoaffective disorder, delusional disorder and/or organic psychosis
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT03449576
Start Date
January 1 2019
End Date
July 1 2022
Last Update
July 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Salem VA Medical Center, Salem, VA
Salem, Virginia, United States, 24153